Analysis: Thomas H. Kean Jr's sale of SYK (Stryker Corp)

Assessment: On watch

Routine liquidation of a healthcare position that actually missed out on a post-earnings rally.

Member: Thomas H. Kean Jr
Party / state: Republican, NJ-7
Chamber: Representatives
Transaction: Sale
Amount: $15,001 - $50,000
Ticker: SYK
Company: Stryker Corp
Trade date: 2026-01-23
Disclosure date: 2026-02-19
Disclosure lag: 27 days

Executive summary

Rep. Thomas H. Kean Jr, a member of the Energy and Commerce Committee (Subcommittee on Health), sold $15,001 - $50,000 of Stryker (SYK) on January 23, 2026. This sale occurred six days prior to the company's Q4 earnings release and was part of a larger divestment pattern in healthcare assets including JNJ and ABT.

The trade is part of a highly consistent liquidation pattern in SYK, with seven sales and zero purchases recorded since February 2025. Notably, the member executed this sale on the exact same day as Senator Ro Khanna, suggesting a potential broader trend or shared sentiment across chambers. The timing of the sale (six days before earnings) and the member's position on the Health Subcommittee, which oversees agencies regulating Stryker (FDA/CMS), are the primary contextual factors. However, the lack of prior purchases in the dataset suggests this may be the systematic liquidation of a pre-existing position rather than a reactive trade to specific non-public information.

Timeline

2025-11-20 — Member sold $15k-$50k of SYK
2026-01-15 — Earnings call date announced for Jan 29
2026-01-23 — SPECIFIC TRADE: Member sold $15k-$50k of SYK
2026-01-23 — Ro Khanna sold $15k-$50k of SYK
2026-01-29 — Stryker Q4 Earnings Release
2026-02-19 — Trade disclosed to House Clerk

Independent analysis of public financial disclosures. Not financial or investment advice.

Sources

Thomas H. Kean Jr · SYK · Trading news